From April 1, 2023 to June 30, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CNY 0 million under the buyback announced on January 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.24 CNY | -0.19% | +11.25% | -5.24% |
1st Jan change | Capi. | |
---|---|---|
-5.24% | 508M | |
+20.37% | 43.54B | |
+19.44% | 21.78B | |
+17.85% | 15.38B | |
+25.55% | 15.12B | |
+60.99% | 13.36B | |
-0.05% | 6.79B | |
-15.02% | 6.38B | |
-8.87% | 5.73B | |
+8.17% | 5.32B |
- Stock Market
- Equities
- 603669 Stock
- News Lionco Pharmaceutical Group Co.,Ltd.
- Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on January 31, 2023.